July 25, 2025 · Form 4 insider transaction
SULLIVAN LOUIS W bought 590 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.; These common stock shares are held indirectly by a trust over which the reporting person has sole investment power and sole voting power.